IDEXX LABORATORIES INC /DE 4

Director Joseph L. Hooley received an equity award of 49 deferred stock units of IDEXX Laboratories, Inc. common stock in lieu of cash fees under the director compensation plan.

On July 30, 2026, director Joseph L. Hooley acquired 49 deferred stock units of IDEXX Laboratories, Inc. common stock at a reference price of approximately $558.80 per share under the company’s Director Deferred Compensation Plan, representing the deferral of $27,280.22 of cash director fees into equity. These deferred stock units vest immediately upon grant but are only deliverable as common stock following his resignation from the Board or on another predetermined, nondiscretionary date specified under the plan. Following this routine compensation-related award, Hooley beneficially owns 325 shares (or equivalent deferred units) of IDEXX Laboratories common stock on a direct basis.

Filing Facts

CIK

874716

Ticker

IDXX

Form

4

Source Type

sec

Accession

0000874716-26-000117

Alert Tier

5